ACN - Accenture plc

NYSE - NYSE Delayed Price. Currency in USD
147.88
+0.99 (+0.67%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close146.89
Open148.78
Bid142.00 x 900
Ask0.00 x 800
Day's Range147.72 - 149.46
52 Week Range132.63 - 175.64
Volume2,677,121
Avg. Volume2,458,064
Market Cap94.266B
Beta (3Y Monthly)1.16
PE Ratio (TTM)22.72
EPS (TTM)6.51
Earnings DateMar 20, 2019 - Mar 25, 2019
Forward Dividend & Yield2.92 (2.01%)
Ex-Dividend Date2018-10-17
1y Target Est170.58
Trade prices are not sourced from all markets
  • Barrons.com7 hours ago

    Morgan Stanley’s Best Services Idea: Accenture Stock

    The provider of services and solutions in strategy, consulting, digital, technology and operations could thrive this year with its leading position in information-technology services.

  • Business Wire2 days ago

    CAQH Develops the First Provider Data Management Solution for Delegated Groups with Support from Accenture

    Accenture (ACN) has helped CAQH, a non-profit healthcare alliance, launch a new technology platform that will streamline professional credentialing and data sharing between delegated health providers and health plans. The new platform replaces today’s highly manual and redundant processes with an online module, CAQH ProView for Groups, that streamlines the roster sharing process between health plans and delegated groups. Provider groups can use the platform to submit a single roster of their delegated providers through a centralized portal, giving plans access to standardized, updated files in one convenient location.

  • Salesforce Updates Commerce Cloud to Uplift Client Experience
    Zacks2 days ago

    Salesforce Updates Commerce Cloud to Uplift Client Experience

    Salesforce (CRM) upgrades Commerce Cloud platform for allowing companies to fashion customized shopping experiences.

  • Thomson Reuters StreetEvents2 days ago

    Edited Transcript of ACN earnings conference call or presentation 20-Dec-18 1:00pm GMT

    Q1 2019 Accenture PLC Earnings Call

  • Accenture Chairman & CEO Resigns, Company Names Interim CEO
    Zacks3 days ago

    Accenture Chairman & CEO Resigns, Company Names Interim CEO

    Accenture (ACN) likely to continue focusing on high-growth areas of digital, cloud and security under new CEO.

  • Accenture Positioned as Leader in Everest Group PEAK Matrix™ Assessment for Blockchain Services
    Business Wire3 days ago

    Accenture Positioned as Leader in Everest Group PEAK Matrix™ Assessment for Blockchain Services

    Accenture has been recognized as a Leader in the Everest Group PEAK Matrix™ Assessment for Blockchain Services, topping its “vision and capability” scale that is a measure of Accenture’s ability to deliver blockchain solutions successfully.

  • Accenture and KPN Collaborate on Industrial 5G Applications
    Zacks5 days ago

    Accenture and KPN Collaborate on Industrial 5G Applications

    The move is part of Accenture's (ACN) bid to expand 5G-enabled applications beyond the communications industry.

  • InvestorPlace5 days ago

    ACN Stock Slips as Accenture CEO Steps Down

    The Accenture CEO (NYSE:ACN) has announced that he will be stepping down from the role after leading the global management consulting firm for nearly a decade. Pierre Nanterme, Chairman and CEO of the Ireland-based company, said that he will be leaving his post as boss after serving the company for eight years under that role. The company added that Nanterme will be stepping down due to health reasons, although the circumstances and condition surrounding these health issues have not been fully revealed to the public. Accenture did reveal back in July 2016 that Nanterme was diagnosed with colon cancer, although it is unclear how advanced the condition is, as well as what type of treatment the boss is currently on as he battles this difficult illness. The consulting firm said that it will put current Chief Financial Officer David Rowland in the position as interim CEO, which means that KC McClure, who is currently in charge of leading finance operations, will take over as CFO for the time being. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Additionally, Accenture's Lead Independent Director Marge Magner will be the company's non-executive chair for the time being. The company also said that there are no changes to its outlook for the results of its second quarter of its fiscal 2019. ACN stock was moving down slightly to the end the week, sliding about 0.5% on Friday. ### More From InvestorPlace * Morgan Stanley: 7 Risky Stocks to Sell Now * 10 Stocks You Can Set and Forget (Even In This Market) * The 7 Best Stocks in the Entrepreneur Index Compare Brokers The post ACN Stock Slips as Accenture CEO Steps Down appeared first on InvestorPlace.

  • TheStreet.com5 days ago

    Accenture CEO Pierre Nanterme Steps Down for Health Reasons

    CEO Pierre Nanterme will step down because of health reasons stemming from a colon cancer diagnosis more than two years ago, the consulting and outsourcing services giant said in a statement. Nanterme, who was diagnosed and had surgery for colon cancer in July 2016, has stepped down, effective immediately, from the helm of the 469,000-employee company he had guided since 2011, Accenture said. Accenture's stock declined slightly on Friday.

  • Accenture CEO steps down due to health reasons
    Reuters6 days ago

    Accenture CEO steps down due to health reasons

    (Reuters) - Accenture Plc's (ACN.N) Chief Executive Officer Pierre Nanterme is stepping down due to health reasons, the consulting and outsourcing company said on Friday. Chief Financial Officer David ...

  • Reuters6 days ago

    Accenture CEO steps down due to health reasons

    Accenture Plc's Chief Executive Officer Pierre Nanterme is stepping down due to health reasons, the consulting and outsourcing company said on Friday. Chief Financial Officer David Rowland will serve as ...

  • MarketWatch6 days ago

    Accenture CEO to step down after 8 years in the role for health reasons

    Accenture PLC said Friday Chairman and Chief Executive Pierre Nanterme has stepped down, after 8 years as CEO, for health reasons. the company has named Chief Financial Officer David Rowland as interim CEO; KC McClure, who currently leads finance operations, as CFO; and Lead Independent Director Marge Magner as its non-executive chair. In July 2016, the company disclosed that Nanterme was diagnosed with colon cancer. The business consultant said there was no change to its outlook for the fiscal second quarter or fiscal 2019. The stock was little changed in premarket trade. It has lost 7.6% over the past 12 months while the S&P 500 has declined 6.2%.

  • Business Wire6 days ago

    Accenture Chairman & CEO Pierre Nanterme Steps Down for Health Reasons; David Rowland Appointed Interim Chief Executive Officer; Marge Magner Named Non-Executive Chair

    Accenture (ACN) announced that effective immediately, Chairman and CEO Pierre Nanterme has stepped down for health reasons that were previously disclosed in July 2016. The company also appointed KC McClure, who currently leads Accenture’s finance operations, as chief financial officer. Nanterme will continue at Accenture as advisor to the CEO.

  • Financial Times6 days ago

    [$$] Accenture CEO steps down for health reasons

    Accenture chairman and chief executive Pierre Nanterme has stepped down for health reasons after running the consultancy for eight years. Mr Nanterme had previously disclosed in 2016 that he was suffering ...

  • Accenture Rides on Buyouts & Cloud, Pricing Pressure Rife
    Zacks6 days ago

    Accenture Rides on Buyouts & Cloud, Pricing Pressure Rife

    While acquisitions increase Accenture's (ACN) revenue opportunities along with business mix and profitability, stiff completion leads to pricing pressure.

  • Accenture Boosts Financial Services With Orbium Buyout
    Zacks7 days ago

    Accenture Boosts Financial Services With Orbium Buyout

    The acquisition is likely to boost Accenture's (ACN) Financial Services segment and enhance its global presence in terms of Avaloq execution.

  • Business Wire7 days ago

    Accenture Collaborates with KPN to Demonstrate the Value of 5G-Enabled Industrial Applications

    Accenture (ACN) is collaborating with Dutch telecommunications company KPN and other innovative businesses in the KPN-led Industrial 5G Field Lab Initiative, located at the Shell Pernis Refinery in the heart of the Rotterdam Harbour area. The goal is to prove the value of 5G applications with customers and technology partners, paving the way for the Netherlands to be a leading European player in 5G adoption. Accenture’s role in the ecosystem is to develop and test industrial applications that use the power of the new generation of mobile networks.

  • Business Wire8 days ago

    Accenture to Acquire Orbium, a Business and Technology Consultancy to the Financial Services Industry

    Accenture (ACN) has agreed to acquire Orbium, a management consultancy and technology services provider to the financial services industry, headquartered in Switzerland. The acquisition will further strengthen Accenture’s ability to provide innovative services to clients in the private-banking and wealth-management space globally. Orbium is the largest services provider for the Avaloq Banking Suite — a leader in digital and core banking software for the banking and wealth management industry, used by more than 150 banks and wealth managers worldwide.

  • Business Wire9 days ago

    Molex, Accenture and Amazon Web Services Co-Develop Edge Computing Solution Powering NextGen Autonomous Vehicles

    CES 2019--Molex is expanding its autonomous and connected vehicle capabilities by working with Accenture (ACN) and Amazon Web Services (AWS) to bring edge computing and voice assistant capabilities to the Molex Automotive Ethernet Network Platform.

  • Ayasdi Named Accenture HealthTech Innovation Challenge Innovation Champion
    Business Wire9 days ago

    Ayasdi Named Accenture HealthTech Innovation Challenge Innovation Champion

    Ayasdi has been named the Accenture HealthTech Innovation Challenge Innovation Champion, competing with more than 1,100 companies for the title. The competition pairs leading-edge startups with prominent health and life sciences organizations to develop innovative technology solutions that improve the way people access and manage healthcare. Ayasdi, based out of Menlo Park, Calif., received the award for its Clinical Variation Management application that uses machine intelligence to identify the optimal way to conduct any surgical or nonsurgical procedure, pulling from electronic health records, billing, claims and other databases to automatically create a clinical care process model.

  • Smart Speaker Usage Booming Worldwide, Accenture Study Finds
    Business Wire9 days ago

    Smart Speaker Usage Booming Worldwide, Accenture Study Finds

    Relevance and trust are key factors for continued adoption of digital voice assistants

  • Will Oracle and Accenture Help Secoo Stay Relevant?
    Motley Fool10 days ago

    Will Oracle and Accenture Help Secoo Stay Relevant?

    The tech giants could help the Chinese e-tailer cut costs and automate its workforce.

  • Investing.com13 days ago

    Accenture Rises 3%

    Investing.com - Accenture (NYSE:ACN) rose by 3.15% to trade at $140.07 by 10:03 (15:03 GMT) on Friday on the NYSE exchange.

  • Investing.com14 days ago

    Accenture Falls 3%

    Investing.com - Accenture (NYSE:ACN) fell by 3.02% to trade at $136.35 by 15:07 (20:07 GMT) on Thursday on the NYSE exchange.

  • Insiders Roundup: Accenture, Apollo
    GuruFocus.com19 days ago

    Insiders Roundup: Accenture, Apollo

    Largest insider trades of the week